Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey.

Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL.

Cancer. 2016 Nov 17. doi: 10.1002/cncr.30417. [Epub ahead of print]

PMID:
27859009
2.

Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.

Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL.

Pediatr Blood Cancer. 2016 Oct 27. doi: 10.1002/pbc.26278. [Epub ahead of print]

PMID:
27786406
3.

The hemifusion structure induced by influenza virus haemagglutinin is determined by physical properties of the target membranes.

Chlanda P, Mekhedov E, Waters H, Schwartz CL, Fischer ER, Ryham RJ, Cohen FS, Blank PS, Zimmerberg J.

Nat Microbiol. 2016 Apr 18;1(6):16050. doi: 10.1038/nmicrobiol.2016.50.

PMID:
27572837
4.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PC, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MC, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS.

Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5.

5.

Modern Management and Diagnosis of Hypertension in the United Kingdom: Home Care and Self-care.

Sheppard JP, Schwartz CL, Tucker KL, McManus RJ.

Ann Glob Health. 2016 Mar-Apr;82(2):274-87. doi: 10.1016/j.aogh.2016.02.005. Review.

6.

Lack of Skeletal Muscle IL-6 Affects Pyruvate Dehydrogenase Activity at Rest and during Prolonged Exercise.

Gudiksen A, Schwartz CL, Bertholdt L, Joensen E, Knudsen JG, Pilegaard H.

PLoS One. 2016 Jun 21;11(6):e0156460. doi: 10.1371/journal.pone.0156460.

7.

The hemifusion structure induced by Influenza virus haemagglutinin is determined by physical properties of the target membranes.

Chlanda P, Mekhedov E, Waters H, Schwartz CL, Fischer ER, Ryham RJ, Cohen FS, Blank PS, Zimmerberg J.

Nat Microbiol. 2016;2016. pii: 16050.

8.

Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.

Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL.

J Clin Oncol. 2016 Jul 10;34(20):2372-9. doi: 10.1200/JCO.2015.65.3469.

PMID:
27185849
9.

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.

Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ.

Pediatr Blood Cancer. 2016 Oct;63(10):1737-43. doi: 10.1002/pbc.26034.

PMID:
27128693
10.

A detailed look at the cytoskeletal architecture of the Giardia lamblia ventral disc.

Brown JR, Schwartz CL, Heumann JM, Dawson SC, Hoenger A.

J Struct Biol. 2016 Apr;194(1):38-48. doi: 10.1016/j.jsb.2016.01.011.

PMID:
26821343
11.

Gold Nanoparticle Quantitation by Whole Cell Tomography.

Sanders AW, Jeerage KM, Schwartz CL, Curtin AE, Chiaramonti AN.

ACS Nano. 2015 Dec 22;9(12):11792-9. doi: 10.1021/acsnano.5b03815.

PMID:
26563983
12.
13.

Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group.

Macpherson CF, Hooke MC, Friedman DL, Campbell K, Withycombe J, Schwartz CL, Kelly K, Meza J.

J Adolesc Young Adult Oncol. 2015 Sep;4(3):137-40. doi: 10.1089/jayao.2015.0013.

14.

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.

Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE.

Pediatr Blood Cancer. 2016 Jan;63(1):54-61. doi: 10.1002/pbc.25753.

PMID:
26398490
15.

Progress toward clonable inorganic nanoparticles.

Ni TW, Staicu LC, Nemeth RS, Schwartz CL, Crawford D, Seligman JD, Hunter WJ, Pilon-Smits EA, Ackerson CJ.

Nanoscale. 2015 Nov 7;7(41):17320-7. doi: 10.1039/c5nr04097c.

16.

Pediatric Hodgkin Lymphoma.

Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D.

J Clin Oncol. 2015 Sep 20;33(27):2975-85. doi: 10.1200/JCO.2014.59.4853. Review.

PMID:
26304892
17.

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH.

J Clin Oncol. 2015 Aug 20;33(24):2639-45. doi: 10.1200/JCO.2014.59.4473.

18.

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.

Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, López-Terrada D, Mrazek MD, Agrawal N, Wu MF, Liu H, De Alarcon PA, Trippet TM, Schwartz CL.

Br J Haematol. 2015 Jul;170(1):118-22. doi: 10.1111/bjh.13388.

19.

Radiotherapy quality assurance report from children's oncology group AHOD0031.

Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1065-71. doi: 10.1016/j.ijrobp.2014.11.034.

PMID:
25670539
20.

Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.

Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):60-6. doi: 10.1016/j.ijrobp.2014.10.042.

Items per page

Supplemental Content

Loading ...
Support Center